Gainers
- Scinai Immunotherapeutics SCNI stock rose 24.9% to $3.11 during Wednesday's pre-market session. The company's market cap stands at $2.3 million.
- Instil Bio TIL shares rose 12.58% to $24.69. The company's market cap stands at $143.8 million.
- Sunshine Biopharma SBFM shares increased by 11.72% to $1.62. The company's market cap stands at $6.6 million.
- Sonnet BioTherapeutics SONN shares increased by 11.57% to $1.35. The market value of their outstanding shares is at $3.8 million.
- Modular Medical MODD shares rose 11.53% to $0.79. The market value of their outstanding shares is at $38.4 million.
- NewGenIvf Group NIVF shares rose 11.11% to $1.1. The company's market cap stands at $4.2 million.
Losers
- Centene CNC shares fell 30.2% to $39.57 during Wednesday's pre-market session. The market value of their outstanding shares is at $28.1 billion.
- Mustang Bio MBIO shares declined by 27.32% to $1.49. The company's market cap stands at $8.9 million.
- Genenta Science GNTA stock decreased by 12.31% to $3.35. The market value of their outstanding shares is at $69.8 million.
- Vaxart VXRT stock declined by 10.86% to $0.41. The market value of their outstanding shares is at $104.9 million.
- Revelation Biosciences REVB shares fell 10.71% to $0.73.
- Soligenix SNGX shares decreased by 9.93% to $1.27. The company's market cap stands at $4.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CNCCentene Corp
$29.144.48%
Edge Rankings
Momentum
5.02
Growth
70.15
Quality
4.53
Value
92.60
Price Trend
Short
Medium
Long
GNTAGenenta Science SPA
$3.60-3.22%
MBIOMustang Bio Inc
$2.09-%
MODDModular Medical Inc
$0.72994.27%
NIVFNewGenIvf Group Ltd
$0.5540-0.02%
REVBRevelation Biosciences Inc
$3.142.92%
SBFMSunshine Biopharma Inc
$1.54-3.14%
SCNIScinai Immunotherapeutics Ltd
$2.23-3.88%
SNGXSoligenix Inc
$1.41-%
SONNSonnet BioTherapeutics Holdings Inc
$4.58-11.1%
TILInstil Bio Inc
$29.674.32%
VXRTVaxart Inc
$0.420031.3%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.